Kevin Cheng

Kevin Cheng is a Partner at MVM Partners LLP, specializing in investing in growth-stage companies in the healthcare sector. Kevin also serves as a Board Member at BioProtect Ltd and OSSIO. With a background in consulting at Bain & Company and research at the Medical Research Council, Kevin's expertise spans across various aspects of the healthcare industry. Kevin holds a PhD in Oncology from the University of Cambridge.